טוען...

Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies

BACKGROUND/PURPOSE: Spasticity is one of the most common symptoms in people with multiple sclerosis (MS). Conventional anti-spasticity agents have limitations in their efficacy and tolerability. Delta-9-tetrahydrocannabinol: cannabidiol (THC:CBD) spray, a cannabinoid-based medicine, is approved as a...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Cent Nerv Syst Dis
Main Authors: Akgün, Katja, Essner, Ute, Seydel, Cordula, Ziemssen, Tjalf
פורמט: Artigo
שפה:Inglês
יצא לאור: SAGE Publications 2019
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6413425/
https://ncbi.nlm.nih.gov/pubmed/30886530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179573519831997
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!